News

Medical Dialogues23h
FDA Approves Dupilumab as First Targeted Treatment for Bullous Pemphigoid
The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...
PMLive2h
Sanofi/Regeneron’s Dupixent granted FDA approval for bullous pemphigoid
Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...
MedPage Today on MSN18hOpinion
'5 Years, 10 Years at Most, I'm Going to Retire': What We Heard This Week
"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...